|
|
||||||||
The Journal of Immunology, Vol 159, Issue 10 4868-4878, Copyright © 1997 by American Association of Immunologists
ARTICLES |
H Zhang, JW Peterson, DW Niesel and GR Klimpel
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston 77555-1019, USA.
Septic shock is a major cause of death in the world. Although much is known about the role of LPS in septic shock, little is known about the role of other bacterial components. Lipoprotein (LP) is a major component of bacteria in the family Enterobacteriaceae. LP purified from Escherichia coli was shown to induce TNF-alpha and IL-6 production in peritoneal exudate macrophages obtained from LPS-responsive (C3H/HeOuJ) and LPS-nonresponsive (C3H/HeJ) mice. LP and LPS acted synergistically to induce cytokine production not only in C3H/HeOuJ macrophages but also in C3H/HeJ macrophages. These results suggest that LPS can induce cellular signaling in C3H/HeJ macrophages, and that LPS and LP activate macrophages via different receptors and/or signaling pathways. The role LP plays in septic shock was investigated using the mouse D-galactosamine model. LP induced lethal shock and in vivo production of TNF-alpha and IL-6 in both LPS-responsive and LPS- nonresponsive mice. LPS failed to induce lethal shock or in vivo cytokine production in C3H/HeJ mice. However, LP and LPS acted synergistically in inducing lethal shock and in vivo cytokine production in both LPS-responsive and LPS-nonresponsive mice. Finally, a heat-killed preparation of an E. coli mutant strain that lacked LP was shown to be less efficient than heat-killed wild-type E. coli at inducing lethal shock in C3H/HeJ mice. Collectively, these results suggest that LP and LPS induce cytokine production via different mechanisms and that LP plays an important role in septic shock induced by bacteria in the family Enterobacteriaceae.
This article has been cited by other articles:
![]() |
J. Sha, S. L. Agar, W. B. Baze, J. P. Olano, A. A. Fadl, T. E. Erova, S. Wang, S. M. Foltz, G. Suarez, V. L. Motin, et al. Braun Lipoprotein (Lpp) Contributes to Virulence of Yersiniae: Potential Role of Lpp in Inducing Bubonic and Pneumonic Plague Infect. Immun., April 1, 2008; 76(4): 1390 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bas, L. Neff, M. Vuillet, U. Spenato, T. Seya, M. Matsumoto, and C. Gabay The Proinflammatory Cytokine Response to Chlamydia trachomatis Elementary Bodies in Human Macrophages Is Partly Mediated by a Lipoprotein, the Macrophage Infectivity Potentiator, through TLR2/TLR1/TLR6 and CD14 J. Immunol., January 15, 2008; 180(2): 1158 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Silver, N. M. Rabinowitz, S. Kuffer, and J. Graf Identification of Aeromonas veronii Genes Required for Colonization of the Medicinal Leech, Hirudo verbana J. Bacteriol., October 1, 2007; 189(19): 6763 - 6772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Coffey, J. H. Wang, R. Kelly, L. Romics Jr., A. O'Callaghan, C. Fiuza, and H. P. Redmond Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality J. Leukoc. Biol., October 1, 2007; 82(4): 906 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Cavaillon and D. Annane Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS Innate Immunity, June 1, 2006; 12(3): 151 - 170. [Abstract] [PDF] |
||||
![]() |
T. A. Richardson, M. Sherman, L. Antonovic, S. S. Kardar, H. W. Strobel, D. Kalman, and E. T. Morgan HEPATIC AND RENAL CYTOCHROME P450 GENE REGULATION DURING CITROBACTER RODENTIUM INFECTION IN WILD-TYPE AND TOLL-LIKE RECEPTOR 4 MUTANT MICE Drug Metab. Dispos., March 1, 2006; 34(3): 354 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Fadl, J. Sha, G. R. Klimpel, J. P. Olano, C. L. Galindo, and A. K. Chopra Attenuation of Salmonella enterica Serovar Typhimurium by Altering Biological Functions of Murein Lipoprotein and Lipopolysaccharide Infect. Immun., December 1, 2005; 73(12): 8433 - 8436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Asai, M. Hashimoto, H. M. Fletcher, K. Miyake, S. Akira, and T. Ogawa Lipopolysaccharide Preparation Extracted from Porphyromonas gingivalis Lipoprotein-Deficient Mutant Shows a Marked Decrease in Toll-Like Receptor 2-Mediated Signaling Infect. Immun., April 1, 2005; 73(4): 2157 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Fadl, J. Sha, G. R. Klimpel, J. P. Olano, D. W. Niesel, and A. K. Chopra Murein Lipoprotein Is a Critical Outer Membrane Component Involved in Salmonella enterica Serovar Typhimurium Systemic Infection Infect. Immun., February 1, 2005; 73(2): 1081 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. O'Brien, J. H. Wang, and H. P. Redmond Bacterial Lipoprotein Induces Resistance to Gram-Negative Sepsis in TLR4-Deficient Mice via Enhanced Bacterial Clearance J. Immunol., January 15, 2005; 174(2): 1020 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Power, J. H. Wang, B. Manning, M. R. Kell, N. F. Aherne, Q. D. Wu, and H. P. Redmond Bacterial Lipoprotein Delays Apoptosis in Human Neutrophils through Inhibition of Caspase-3 Activity: Regulatory Roles for CD14 and TLR-2 J. Immunol., October 15, 2004; 173(8): 5229 - 5237. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sha, A. A. Fadl, G. R. Klimpel, D. W. Niesel, V. L. Popov, and A. K. Chopra The Two Murein Lipoproteins of Salmonella enterica Serovar Typhimurium Contribute to the Virulence of the Organism Infect. Immun., July 1, 2004; 72(7): 3987 - 4003. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Silverstein Review: D-Galactosamine lethality model: scope and limitations Innate Immunity, June 1, 2004; 10(3): 147 - 162. [Abstract] [PDF] |
||||
![]() |
A. Bjerre, B. Brusletto, R. Ovstebo, G. B. Joo, P. Kierulf, and P. Brandtzaeg Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex Innate Immunity, June 1, 2003; 9(3): 155 - 163. [Abstract] [PDF] |
||||
![]() |
O. Equils, M. L. Schito, H. Karahashi, Z. Madak, A. Yarali, K. S. Michelsen, A. Sher, and M. Arditi Toll-Like Receptor 2 (TLR2) and TLR9 Signaling Results in HIV-Long Terminal Repeat Trans-Activation and HIV Replication in HIV-1 Transgenic Mouse Spleen Cells: Implications of Simultaneous Activation of TLRs on HIV Replication J. Immunol., May 15, 2003; 170(10): 5159 - 5164. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Wang, M. Doyle, B. J. Manning, S. Blankson, Q. D. Wu, C. Power, R. Cahill, and H. P. Redmond Cutting Edge: Bacterial Lipoprotein Induces Endotoxin-Independent Tolerance to Septic Shock J. Immunol., January 1, 2003; 170(1): 14 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Wang, M. Doyle, B. J. Manning, Q. Di Wu, S. Blankson, and H. P. Redmond Induction of Bacterial Lipoprotein Tolerance Is Associated with Suppression of Toll-like Receptor 2 Expression J. Biol. Chem., September 20, 2002; 277(39): 36068 - 36075. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tsuboi, Y. Yoshikai, S. Matsuo, T. Kikuchi, K.-I. Iwami, Y. Nagai, O. Takeuchi, S. Akira, and T. Matsuguchi Roles of Toll-Like Receptors in C-C Chemokine Production by Renal Tubular Epithelial Cells J. Immunol., August 15, 2002; 169(4): 2026 - 2033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yasuda, M. Nagaki, and H. Moriwaki Staphylococcal enterotoxin B induces hepatic injury and lethal shock in endotoxin-resistant C3H/HeJ mice despite a deficient macrophage response Innate Immunity, August 1, 2002; 8(4): 253 - 261. [Abstract] [PDF] |
||||
![]() |
J. Hellman, J. D. Roberts Jr., M. M. Tehan, J. E. Allaire, and H. S. Warren Bacterial Peptidoglycan-associated Lipoprotein Is Released into the Bloodstream in Gram-negative Sepsis and Causes Inflammation and Death in Mice J. Biol. Chem., April 12, 2002; 277(16): 14274 - 14280. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. Yi, J.-G. Yoon, S.-C. Hong, T. W. Redford, and A. M. Krieg Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-{alpha} production through activation of NF-{kappa}B Int. Immunol., November 1, 2001; 13(11): 1391 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Neilsen, G. A. Zimmerman, and T. M. McIntyre Escherichia coli Braun Lipoprotein Induces a Lipopolysaccharide-Like Endotoxic Response from Primary Human Endothelial Cells J. Immunol., November 1, 2001; 167(9): 5231 - 5239. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hirata, K. Hiramatsu, K. Kishi, T. Yamasaki, T. Ichimiya, and M. Nasu Pretreatment of Mice with Clindamycin Improves Survival of Endotoxic Shock by Modulating the Release of Inflammatory Cytokines Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2638 - 2642. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Aliprantis, D. S. Weiss, and A. Zychlinsky Toll-like receptor-2 transduces signals for NF-{kappa}B activation, apoptosis and reactive oxygen species production Innate Immunity, August 1, 2001; 7(4): 287 - 291. [Abstract] [PDF] |
||||
![]() |
M. Hirschfeld, J. J. Weis, V. Toshchakov, C. A. Salkowski, M. J. Cody, D. C. Ward, N. Qureshi, S. M. Michalek, and S. N. Vogel Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine Macrophages Infect. Immun., March 1, 2001; 69(3): 1477 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hellman and H. Shaw Warren Outer membrane protein A (OmpA), peptidoglycan-associated lipoprotein (PAL), and murein lipoprotein (MLP) are released in experimental Gram-negative sepsis Innate Immunity, February 1, 2001; 7(1): 69 - 72. [Abstract] [PDF] |
||||
![]() |
E. Faure, L. Thomas, H. Xu, A. E. Medvedev, O. Equils, and M. Arditi Bacterial Lipopolysaccharide and IFN-{{gamma}} Induce Toll-Like Receptor 2 and Toll-Like Receptor 4 Expression in Human Endothelial Cells: Role of NF-{{kappa}}B Activation J. Immunol., February 1, 2001; 166(3): 2018 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sato, F. Nomura, T. Kawai, O. Takeuchi, P. F. Muhlradt, K. Takeda, and S. Akira Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways J. Immunol., December 15, 2000; 165(12): 7096 - 7101. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Fortney, R. S. Young, M. E. Bauer, B. P. Katz, A. F. Hood, R. S. Munson Jr., and S. M. Spinola Expression of Peptidoglycan-Associated Lipoprotein Is Required for Virulence in the Human Model of Haemophilus ducreyi Infection Infect. Immun., November 1, 2000; 68(11): 6441 - 6448. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirschfeld, Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 2 J. Immunol., July 15, 2000; 165(2): 618 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hellman, P. M. Loiselle, M. M. Tehan, J. E. Allaire, L. A. Boyle, J. T. Kurnick, D. M. Andrews, K. Sik Kim, and H. S. Warren Outer Membrane Protein A, Peptidoglycan-Associated Lipoprotein, and Murein Lipoprotein Are Released by Escherichia coli Bacteria into Serum Infect. Immun., May 1, 2000; 68(5): 2566 - 2572. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Faure, O. Equils, P. A. Sieling, L. Thomas, F. X. Zhang, C. J. Kirschning, N. Polentarutti, M. Muzio, and M. Arditi Bacterial Lipopolysaccharide Activates NF-kappa B through Toll-like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial Cells. DIFFERENTIAL EXPRESSION OF TLR-4 AND TLR-2 IN ENDOTHELIAL CELLS J. Biol. Chem., April 6, 2000; 275(15): 11058 - 11063. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Soler-Rodriguez, H. Zhang, H. S. Lichenstein, N. Qureshi, D. W. Niesel, S. E. Crowe, J. W. Peterson, and G. R. Klimpel Neutrophil Activation by Bacterial Lipoprotein Versus Lipopolysaccharide: Differential Requirements for Serum and CD14 J. Immunol., March 1, 2000; 164(5): 2674 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirschfeld, C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis Cutting Edge: Inflammatory Signaling by Borrelia burgdorferi Lipoproteins Is Mediated by Toll-Like Receptor 2 J. Immunol., September 1, 1999; 163(5): 2382 - 2386. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Sellati, D. A. Bouis, M. J. Caimano, J. A. Feulner, C. Ayers, E. Lien, and J. D. Radolf Activation of Human Monocytic Cells by Borrelia burgdorferi and Treponema pallidum Is Facilitated by CD14 and Correlates with Surface Exposure of Spirochetal Lipoproteins J. Immunol., August 15, 1999; 163(4): 2049 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Aliprantis, R. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2 Science, July 30, 1999; 285(5428): 736 - 739. [Abstract] [Full Text] |
||||
![]() |
H. Zhang, D. W. Niesel, J. W. Peterson, and G. R. Klimpel Lipoprotein Release by Bacteria: Potential Factor in Bacterial Pathogenesis Infect. Immun., November 1, 1998; 66(11): 5196 - 5201. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Amura, R. Silverstein, and D. C. Morrison Mechanisms Involved in the Pathogenesis of Sepsis Are Not Necessarily Reflected by In Vitro Cell Activation Studies Infect. Immun., November 1, 1998; 66(11): 5372 - 5378. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |